These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25639711)

  • 1. The relationship of alcohol use disorders and depressive symptoms to tryptophan metabolism: cross-sectional data from a Nepalese alcohol treatment sample.
    Neupane SP; Lien L; Martinez P; Hestad K; Bramness JG
    Alcohol Clin Exp Res; 2015 Mar; 39(3):514-21. PubMed ID: 25639711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders.
    Neupane SP; Lien L; Ueland T; Mollnes TE; Aukrust P; Bramness JG
    Alcohol; 2015 Aug; 49(5):471-8. PubMed ID: 25873205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity.
    Vidal R; García-Marchena N; O'Shea E; Requena-Ocaña N; Flores-López M; Araos P; Serrano A; Suárez J; Rubio G; Rodríguez de Fonseca F; Colado MI; Pavón FJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Aug; 102():109958. PubMed ID: 32360814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood homocysteine concentration and mood disorders with mixed features among patients with alcohol use disorder.
    Oliva F; Coppola M; Mondola R; Ascheri D; Cuniberti F; Nibbio G; Picci RL
    BMC Psychiatry; 2017 May; 17(1):181. PubMed ID: 28494779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D deficiency in alcohol-use disorders and its relationship to comorbid major depression: a cross-sectional study of inpatients in Nepal.
    Neupane SP; Lien L; Hilberg T; Bramness JG
    Drug Alcohol Depend; 2013 Dec; 133(2):480-5. PubMed ID: 23916323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and correlates of major depression among Nepalese patients in treatment for alcohol-use disorders.
    Neupane SP; Bramness JG
    Drug Alcohol Rev; 2013 Mar; 32(2):170-7. PubMed ID: 22747513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans.
    Martinez P; Tsai AC; Muzoora C; Kembabazi A; Weiser SD; Huang Y; Haberer JE; Martin JN; Bangsberg DR; Hunt PW
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):456-62. PubMed ID: 24220289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
    Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
    J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms.
    Comai S; Nunez N; Atkin T; Ghabrash MF; Zakarian R; Fielding A; Saint-Laurent M; Low N; Sauber G; Ragazzi E; Hillard CJ; Gobbi G
    BMC Med; 2024 Jan; 22(1):33. PubMed ID: 38273283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
    Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
    J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder.
    Mukherjee D; Krishnamurthy VB; Millett CE; Reider A; Can A; Groer M; Fuchs D; Postolache TT; Saunders EFH
    Bipolar Disord; 2018 Feb; 20(1):27-34. PubMed ID: 28833866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan and Kynurenine Levels and Its Association With Sleep, Nonphysical Fatigue, and Depression in Chronic Hemodialysis Patients.
    Malhotra R; Persic V; Zhang W; Brown J; Tao X; Rosales L; Thijssen S; Finkelstein FO; Unruh ML; Ikizler A; Garimella PS; Ix JH; Kooman J; Levin NW; Handelman GJ; Kotanko P
    J Ren Nutr; 2017 Jul; 27(4):260-266. PubMed ID: 28366444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Alcohol Symptom Checklist identifies high rates of alcohol use disorder in primary care patients who screen positive for depression and high-risk drinking.
    Ryan ED; Chang YM; Oliver M; Bradley KA; Hallgren KA
    BMC Health Serv Res; 2022 Sep; 22(1):1123. PubMed ID: 36064354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers.
    Dahl J; Andreassen OA; Verkerk R; Malt UF; Sandvik L; Brundin L; Ormstad H
    Psychoneuroendocrinology; 2015 Jun; 56():12-22. PubMed ID: 25770856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid post-traumatic stress disorder in alcohol use disorder: relationships to demography, drinking and neuroimmune profile.
    Neupane SP; Bramness JG; Lien L
    BMC Psychiatry; 2017 Aug; 17(1):312. PubMed ID: 28851339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders.
    García-Marchena N; Silva-Peña D; Martín-Velasco AI; Villanúa MÁ; Araos P; Pedraz M; Maza-Quiroga R; Romero-Sanchiz P; Rubio G; Castilla-Ortega E; Suárez J; Rodríguez de Fonseca F; Serrano A; Pavón FJ
    PLoS One; 2017; 12(11):e0187634. PubMed ID: 29108028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise affects symptom severity but not biological measures in depression and somatization - results on IL-6, neopterin, tryptophan, kynurenine and 5-HIAA.
    Hennings A; Schwarz MJ; Riemer S; Stapf TM; Selberdinger VB; Rief W
    Psychiatry Res; 2013 Dec; 210(3):925-33. PubMed ID: 24140252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in tryptophan metabolism during pregnancy and postpartum periods: Potential involvement in postpartum depressive symptoms.
    Teshigawara T; Mouri A; Kubo H; Nakamura Y; Shiino T; Okada T; Morikawa M; Nabeshima T; Ozaki N; Yamamoto Y; Saito K
    J Affect Disord; 2019 Aug; 255():168-176. PubMed ID: 31158779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites.
    Aarsland TI; Leskauskaite I; Midttun Ø; Ulvik A; Ueland PM; Oltedal L; Erchinger VJ; Oedegaard KJ; Haavik J; Kessler U
    Brain Stimul; 2019; 12(5):1135-1142. PubMed ID: 31176607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study.
    Karu N; McKercher C; Nichols DS; Davies N; Shellie RA; Hilder EF; Jose MD
    BMC Nephrol; 2016 Nov; 17(1):171. PubMed ID: 27832762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.